Quantitative analysis of [11C]AZ10419369 binding to 5-HT 1B receptors in human brain(414 views) Varnäs K, Nyberg S, Halldin C, Varrone A, Takano A, Karlsson P, Andersson J, McCarthy D, Smith M, Pierson ME, Söderström J, Farde L
Department of Clinical Neuroscience, Karolinska Institutet, Karolinska University Hospital, SE-17176 Stockholm, Sweden
AstraZeneca Pharmaceuticals Clinical Neuroscience, Södertälje, Sweden
References: H̊lander-Lüttgen, M., Madjid, N., Schött, P.A., Sandin, J., Ögren, S.O., Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat (2003) Neuropsychopharmacology, 28, pp. 1642-5
Akaike, H., A new look at the statistical model identification (1974) IEEE Trans Automat Contr, 19, pp. 716-23
Barnes, N.M., Sharp, T., A review of central 5-HT receptors and their function (1999) Neuropharmacology, 38, pp. 1083-152
Bonaventure, P., Schotte, A., Cras, P., Leysen, J.E., Autoradiographic mapping of 5-HT1B-and 5-HT1D receptors in human brain using [3H]alniditan, a new radioligand (1997) Receptors Channels, 5, pp. 225-30
Engel, G., Göthert, M., Hoyer, D., Schlicker, E., Hillenbrand, K., Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites (1986) Naunyn Schmiedebergs Arch Pharmacol, 332, pp. 1-7
Eriksson, L., Holte, S., Bohm, C., Kesselberg, M., Hovander, B., Automated blood sampling systems for positron emission tomography (1988) IEEE Trans Nucl Sci, 35, pp. 703-7
Farde, L., Eriksson, L., Blomquist, G., Halldin, C., Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET-A comparison to the equilibrium analysis (1989) J Cereb Blood Flow Metab, 9, pp. 696-708
Gallezot, J.D., Nabulsi, N., Neumeister, A., Planeta-Wilson, B., Williams, W.A., Singhal, T., Kim, S., Carson, R.E., Kinetic modeling of the serotonin 5-HT1B receptor radioligand [11C]P943 in humans (2010) J Cereb Blood Flow Metab, 30, pp. 196-210
Gingrich, J.A., Hen, R., Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice (2001) Psychopharmacology (Berl), 155, pp. 1-10
Halldin, C., Swahn, C.G., Farde, L., Sedvall, G., Radioligand disposition and metabolism (1995) PET for Drug Development and Evaluation, pp. 55-65. , (Comar D, ed), Kluwer Academic Publishers: Dordrecht, The Netherlands
Hoyer, D., Hannon, J.P., Martin, G.R., Molecular, pharmacological and functional diversity of 5-HT receptors (2002) Pharmacol Biochem Behav, 71, pp. 533-54
Huang, S.C., Barrio, J.R., Phelps, M.E., Neuroreceptor assay with positron emission tomography: Equilibrium versus dynamic approaches (1986) J Cereb Blood Flow Metab, 6, pp. 515-21
Innis, R.B., Cunningham, V.J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R.N., Holden, J., Carson, R.E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-9
Lammertsma, A.A., Hume, S.P., Simplified reference tissue model for PET receptor studies (1996) Neuroimage, 4, pp. 153-8
Lee, M.D., Simansky, K.J., CP-94, 253: A selective serotonin1B (5-HT1B) agonist thatpromotes satiety (1997) Psychopharmacology (Berl), 131, pp. 264-70
Leenders, K.L., Perani, D., Lammertsma, A.A., Heather, J.D., Buckingham, P., Healy, M.J., Gibbs Jmwise, R.J., Jones, T., Cerebral blood flow, blood volume and oxygen utilization. Normalvalues and effect of age (1990) Brain, 113, pp. 27-47
Lin, D., Parsons, L.H., Anxiogenic-like effect of serotonin1B receptor stimulation in the rat elevated plus-maze (2002) Pharmacol Biochem Behav, 71, pp. 581-7
Logan, J., Fowler, J.S., Volkow, N.D., Wang, G.J., Ding, Y.S., Alexoff, D.L., Distribution volume ratios without blood sampling from graphical analysis of PET data (1996) J Cereb Blood Flow Metab, 16, pp. 834-40
Maier, D.L., Sobotka-Briner, C., Ding, M., Powell, M.E., Jiang, Q., Hill, G., Heys, J.R., Mrzljak, L., [N-methyl-3H3] AZ10419369 binding to the 5-HT1B receptor: In vitro characterization and in vivo receptor occupancy (2009) J Pharmacol Exp Ther, 330, pp. 342-51
Malleret, G., Hen, R., Guillou, J.L., Segu, L., Buhot, M.C., 5-HT1B receptor knock-out mice exhibit increased exploratory activity and enhanced spatial memory performance in the Morris water maze (1999) J Neurosci, 19, pp. 6157-68
Maura, G., Raiteri, M., Cholinergic terminals in rat hippocampus possess 5-HT1B receptors mediating inhibition of acetylcholine release (1986) Eur J Pharmacol, 129, pp. 333-7
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.R., Huang, Y., Laruelle, M., Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D2 receptor parameter measurements in ventral striatum (2001) J Cereb Blood Flow Metab, 21, pp. 1034-57
Mintun, M.A., Raichle, M.E., Kilbourn, M.R., Wooten, G.F., Welch, M.J., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984) Ann Neurol, 15, pp. 217-27
Olsson, H., Farde, L., Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy-A simulation study based on experimental data (2001) Neuroimage, 14, pp. 936-45
Pierson, M.E., Andersson, J., Nyberg, S., McCarthy, D.J., Finnema, S.J., Varnäs, K., Takano, A., Halldin, C., [11C] AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET) Characterization in the primate brain (2008) Neuroimage, 41, pp. 1075-85
Ramboz, S., Saudou, F., Amara, D.A., Belzung, C., Segu, L., Misslin, R., Buhot, M.C., Hen, R., 5-HT1B receptor knock out-behavioral consequences (1996) Behav Brain Res, 73, pp. 305-12
Rocha, B.A., Scearce-Levie, K., Lucas, J.J., Hiroi, N., Castanon, N., Crabbe, J.C., Nestler, E.J., Hen, R., Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor (1998) Nature, 393, pp. 175-8
Roland, P.E., Graufelds, C.J., Wählin, L., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Zilles, K., Human Brain Atlas: For high-resolution functional and anatomical mapping (1994) Hum Brain Mapp, 1, pp. 173-84
Ruf, B.M., Bhagwagar, Z., The 5-HT1B receptor: A novel target for the pathophysiology of depression (2009) Curr Drug Targets, 10, pp. 1118-38
Sarhan, H., Grimaldi, B., Hen, R., Fillion, G., 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes: Further evidence using 5-HT moduline, polyclonal 5-HT1B receptor antibodies and 5-HT1B receptor knock-out mice (2000) Naunyn Schmiedebergs Arch Pharmacol, 361, pp. 12-8
Sari, Y., Miquel, M.C., Brisorgueil, M.J., Ruiz, G., Doucet, E., Hamon, M., Vergé, D., Cellular and subcellular localization of 5-hydroxytryptamine1B receptors in the rat central nervous system: Immunocytochemical, autoradiographic and lesion studies (1999) Neuroscience, 88, pp. 899-915
Svarer, C., Madsen, K., Hasselbalch, S.G., Pinborg, L.H., Haugbøl, S., Frøkjær, V.G., Holm, S., Knudsen, G.M., MR-based automatic delineation of volumes of interest in human brain PET images using probability maps (2005) Neuroimage, 24, pp. 969-79
Varnäs, K., Hall, H., Bonaventure, P., Sedvall, G., Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the postmortem human brain using [3H] GR 125743 (2001) Brain Res, 915, pp. 47-57
Varnäs, K., Halldin, C., Hall, H., Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain (2004) Hum Brain Mapp, 22, pp. 246-60
Wienhard, K., Dahlbom, M., Eriksson, L., Michel, C., Bruckbauer, T., Pietrzyk, U., Heiss, W.D., The ECAT EXACT HR: Performance of a new high resolution positron scanner (1994) J Comput Assist Tomogr, 18, pp. 110-8
Wong, D.F., Gjedde, A., Wagner Jr., H.N., Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands (1986) J Cereb Blood Flow Metab, 6, pp. 137-46
H lander-L ttgen, M., Madjid, N., Sch tt, P. A., Sandin, J., gren, S. O., Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat (2003) Neuropsychopharmacology, 28, pp. 1642-5
Barnes, N. M., Sharp, T., A review of central 5-HT receptors and their function (1999) Neuropharmacology, 38, pp. 1083-152
Crabbe, J. C., Phillips, T. J., Feller, D. J., Hen, R., Wenger, C. D., Lessov, C. N., Schafer, G. L., Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors (1996) Nat Genet, 14, pp. 98-101
Engel, G., G thert, M., Hoyer, D., Schlicker, E., Hillenbrand, K., Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites (1986) Naunyn Schmiedebergs Arch Pharmacol, 332, pp. 1-7
Gallezot, J. D., Nabulsi, N., Neumeister, A., Planeta-Wilson, B., Williams, W. A., Singhal, T., Kim, S., Carson, R. E., Kinetic modeling of the serotonin 5-HT1B receptor radioligand [11C] P943 in humans (2010) J Cereb Blood Flow Metab, 30, pp. 196-210
Gingrich, J. A., Hen, R., Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice (2001) Psychopharmacology (Berl), 155, pp. 1-10
Huang, S. C., Barrio, J. R., Phelps, M. E., Neuroreceptor assay with positron emission tomography: Equilibrium versus dynamic approaches (1986) J Cereb Blood Flow Metab, 6, pp. 515-21
Innis, R. B., Cunningham, V. J., Delforge, J., Fujita, M., Gjedde, A., Gunn, R. N., Holden, J., Carson, R. E., Consensus nomenclature for in vivo imaging of reversibly binding radioligands (2007) J Cereb Blood Flow Metab, 27, pp. 1533-9
Lammertsma, A. A., Hume, S. P., Simplified reference tissue model for PET receptor studies (1996) Neuroimage, 4, pp. 153-8
Lee, M. D., Simansky, K. J., CP-94, 253: A selective serotonin1B (5-HT1B) agonist thatpromotes satiety (1997) Psychopharmacology (Berl), 131, pp. 264-70
Leenders, K. L., Perani, D., Lammertsma, A. A., Heather, J. D., Buckingham, P., Healy, M. J., Gibbs Jmwise, R. J., Jones, T., Cerebral blood flow, blood volume and oxygen utilization. Normalvalues and effect of age (1990) Brain, 113, pp. 27-47
Maier, D. L., Sobotka-Briner, C., Ding, M., Powell, M. E., Jiang, Q., Hill, G., Heys, J. R., Mrzljak, L., [N-methyl-3H3] AZ10419369 binding to the 5-HT1B receptor: In vitro characterization and in vivo receptor occupancy (2009) J Pharmacol Exp Ther, 330, pp. 342-51
Mintun, M. A., Raichle, M. E., Kilbourn, M. R., Wooten, G. F., Welch, M. J., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography (1984) Ann Neurol, 15, pp. 217-27
Pierson, M. E., Andersson, J., Nyberg, S., McCarthy, D. J., Finnema, S. J., Varn s, K., Takano, A., Halldin, C., [11C] AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET) Characterization in the primate brain (2008) Neuroimage, 41, pp. 1075-85
Rocha, B. A., Scearce-Levie, K., Lucas, J. J., Hiroi, N., Castanon, N., Crabbe, J. C., Nestler, E. J., Hen, R., Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor (1998) Nature, 393, pp. 175-8
Roland, P. E., Graufelds, C. J., W hlin, L., Ingelman, L., Andersson, M., Ledberg, A., Pedersen, J., Zilles, K., Human Brain Atlas: For high-resolution functional and anatomical mapping (1994) Hum Brain Mapp, 1, pp. 173-84
Ruf, B. M., Bhagwagar, Z., The 5-HT1B receptor: A novel target for the pathophysiology of depression (2009) Curr Drug Targets, 10, pp. 1118-38
Varn s, K., Hall, H., Bonaventure, P., Sedvall, G., Autoradiographic mapping of 5-HT1B and 5-HT1D receptors in the postmortem human brain using [3H] GR 125743 (2001) Brain Res, 915, pp. 47-57
Varn s, K., Halldin, C., Hall, H., Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain (2004) Hum Brain Mapp, 22, pp. 246-60
Wong, D. F., Gjedde, A., Wagner Jr., H. N., Quantification of neuroreceptors in the living human brain. I. Irreversible binding of ligands (1986) J Cereb Blood Flow Metab, 6, pp. 137-46
Quantitative analysis of [11C]AZ10419369 binding to 5-HT 1B receptors in human brain
Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, Mckiddie F, O'connor M, Prvuolovich E, Underwood R * 3. 0 T perfusion MR imaging(694 views) Rivista Di Neuroradiologia (ISSN: 1120-9976), 2004; 17(6): 807-812. Impact Factor:0.023 ViewExport to BibTeXExport to EndNote